See also this year's filing and all EDGAR filings for this company.
PDF Report 0001622229_2023_Cogent_Biosciences_Inc.pdf
Logs
Graph
Absolute values for 0001622229, Cogent Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 264,966,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,783,000 |
| 3 | remainder_Assets | 28,061,000 |
| 4 | LiabilitiesCurrent | 26,849,000 |
| 5 | LiabilitiesNoncurrent | 18,226,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 26,212,000 |
| 9 | ResearchAndDevelopmentExpense | 121,627,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 7,598,000 |
| 13 | remainder_ComprehensiveNetIncome | -104,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 300,810,000 |
| 1 | Liabilities | 45,075,000 |
| 2 | Expenses | 147,839,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 255,735,000 |
| 5 | NetIncome | -140,241,000 |
| 6 | ComprehensiveNetIncome | -140,293,000 |
| 7 | BaseVar | 250,713,000 |
| 8 | EconomicCapitalRatio | 1.73 |
Edgar->Model Mapping
Feature Distribution
Change over Time
